← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Kinemed, Inc.
Emeryville, CA
$7,575,486
Total funding
7
Grants
Funding over time
peak $1.8M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$7,575,486 · 7
By mechanism
R44$5,841,983 · 2
R43$1,118,603 · 3
R21$389,813 · 1
N43$225,087 · 1
Investigators at Kinemed, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Kinetic Biomarker for CLL Prognosis$1,286,500
R44 · FY2006 · CA
Kinetic Biomarker for CLL Prognosis$1,261,275
R44 · FY2005 · CA
Kinetic Biomarker for CLL Prognosis$1,237,577
R44 · FY2004 · CA
Kinetic Biomarker for CLL Prognosis$679,502
R44 · FY2007 · CA
The application of human collagen kinetic biomarkers to anti-fibrotic drug develo$669,082
R44 · FY2010 · CA
The application of human collagen kinetic biomarkers to anti-fibrotic drug develo$554,823
R44 · FY2009 · CA
In Vivo Kinetic Biomarkers of Hepatic Toxicity$250,000
R43 · FY2005 · CA
An in Vivo Neurogenesis Assay to Discover Antidepressants and Cognitive Enhancers$249,998
R43 · FY2008 · MH
An in Vivo Neurogenesis Assay to Discover Antidepressants and Cognitive Enhancers$249,998
R43 · FY2007 · MH
In Vivo Kinetic Biomarkers of Hepatic Toxicity$244,086
R43 · FY2004 · CA
IGF::OT::IGF Kinetic Biomarkers of Myocardial Fibrogenesis - SBIR Topic 072 - Pha$225,087
N43 · FY2013 · HL
Kinetic Biomarkers of Joint Space Molecules in OA$212,625
R21 · FY2005 · AG
Kinetic Biomarkers of Joint Space Molecules in OA$177,188
R21 · FY2004 · AG
Kinetic Biomarker for CLL Prognosis$153,224
R44 · FY2003 · CA
A Novel Biomarker for Myelin Synthesis$124,521
R43 · FY2005 · NS